All In Biotech

Drug Trial Radar · NCT06419608

Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of BHV-7000 Monotherapy in Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 336 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

336

Actual

Start

May 28, 2024

Primary completion

Nov 7, 2025

Study completion Nov 7, 2025

Sponsor

Lead sponsor
Biohaven Therapeutics Ltd.Industry
Sponsor type
Industry
First posted
May 17, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the efficacy and safety of BHV-7000 in participants with Major Depressive Disorder (MDD)

Conditions

  • Major Depressive Disorder

Interventions

  • BHV-7000Drug

    BHV-7000 75 mg taken once daily for 6 weeks

  • PlaceboDrug

    Matching placebo taken once daily for 6 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Montgomery- Åsberg Depression Rating Scale (MADRS) total score from baseline to week 6Time frame: Baseline to Week 6

Locations

62 sites in 1 country. Site status is shown where the registry gives one.

  • IMA Clinical Research

    Phoenix, Arizona

  • Pillar Clinical Research, LLC

    Little Rock, Arkansas

  • WIRG

    Little Rock, Arkansas

  • WRN

    Rogers, Arkansas

  • Advanced Research Center, Inc.

    Anaheim, California

  • CIT LA

    Bellflower, California

  • IPMG

    Chino, California

  • WR-PRI Encino

    Encino, California

  • Collaborative Neuroscience Research, LLC (CenExel - CNS)

    Garden Grove, California

  • CalNeuro Research Group

    Los Angeles, California

  • Excell Research, Inc.

    Oceanside, California

  • NRC Research Institute

    Orange, California

  • Anderson Clinical Research

    Redlands, California

  • CIT IE

    Riverside, California

  • Lumos Clinical Research Center

    San Jose, California

  • Stanford

    Stanford, California

  • Cenexel CNS

    Torrance, California

  • Pacific Clinical Research Management Group

    Upland, California

  • Sunwise Clinical Research

    Walnut Creek, California

  • MCB Clinical Research Centers

    Colorado Springs, Colorado

  • UConn Health

    Farmington, Connecticut

  • Optum Behavioral Care of Connecticut, PC dba Comprehensive Psychiatric Care of Connecticut

    Norwich, Connecticut

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida

  • Floridian Neuroscience Institute

    Miami Lakes, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • K2 Medical Research

    Tampa, Florida

  • Neuroscience Research Institute

    West Palm Beach, Florida

  • CenExel iResearch, LLC

    Decatur, Georgia

  • CenExel iResearch, LLC

    Savannah, Georgia

  • Uptown Research Institute

    Chicago, Illinois

  • Revive Research Institute, Inc.

    Elgin, Illinois

  • Collective Medical Research

    Overland Park, Kansas

  • Delricht Research

    New Orleans, Louisiana

  • Headlands Pharmasite

    Baltimore, Maryland

  • CBH Health

    Gaithersburg, Maryland

  • Copley Clinical

    Boston, Massachusetts

  • Boston Clinical Trials

    Boston, Massachusetts

  • Adams Clinical

    Watertown, Massachusetts

  • Precise Clinical Research

    Flowood, Mississippi

  • Arch Clinical Trials

    St Louis, Missouri

Showing 40 of 62 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.